2018
DOI: 10.1016/j.bbagen.2018.07.022
|View full text |Cite
|
Sign up to set email alerts
|

Structural basis for the hepatoprotective effects of antihypertensive 1,4-dihydropyridine drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 42 publications
0
3
0
Order By: Relevance
“…Neovascularization induced by TNF-α was found to be inhibited by nifidepine and its analogues [ 117 ]. The antioxidant features, GABA receptor inhibition, and analgesic properties [ 118 ]; hepatoprotective [ 119 , 120 ]; antifungal [ 121 , 122 ]; antiplatelet [ 123 , 124 ]; and bronchodilatory activities [ 125 ] are other features of DHPMs depending on their decorated functionalities and substituents.…”
Section: Other Therapeutic Accomplishments Of Dihydroyrimidinesmentioning
confidence: 99%
“…Neovascularization induced by TNF-α was found to be inhibited by nifidepine and its analogues [ 117 ]. The antioxidant features, GABA receptor inhibition, and analgesic properties [ 118 ]; hepatoprotective [ 119 , 120 ]; antifungal [ 121 , 122 ]; antiplatelet [ 123 , 124 ]; and bronchodilatory activities [ 125 ] are other features of DHPMs depending on their decorated functionalities and substituents.…”
Section: Other Therapeutic Accomplishments Of Dihydroyrimidinesmentioning
confidence: 99%
“…The FXR agonists include steroid compounds such as BAs and their derivatives, 17β-(4-hydroxybenzoyl) androsta-3,5-diene-3-carboxylic acid (MFA-1), and non-steroid ligands including isoxazole GW4064 and derivatives (Feng et al, 2009), benzopyran fexaramine and derivatives (Downes et al, 2003), azapyrene WAY-362450 and derivatives (Flatt et al, 2009), benzimidazolyl amide compounds (Richter et al, 2011), etc. Additionally, some drugs on the market are identified as novel FXR modulators and have been repurposed to show promising potential in treating BA-mediated diseases by targeting FXR, such as the anti-parasitic drug ivermectin and its analogues (Jin et al, 2013(Jin et al, , 2015, and anti-hypertension drugs 1,4-dihydropyridines (DHPs) (Wei et al, 2018). There are also many natural products identified as FXR ligands.…”
Section: Drug Discovery By Targeting Fxrmentioning
confidence: 99%
“…Dihydropyridines are well‐known effective calcium channel blocker drugs for the treatment of hypertension and cardiovascular diseases. [ 7 ] Combining the core structures of spirooxindole and dihydropyridine in a new molecular hybrid exhibits synergic properties in programmed drug design and further evaluation. The use of combinatorial methods by multi‐component reaction for the high‐throughput synthesis of this drug‐like scaffold will be a powerful tool to help accelerate drug discovery.…”
Section: Introductionmentioning
confidence: 99%